Stella Chemifa Corporation (4109) Stock Overview

Stella Chemifa Corporation manufactures and sells inorganic fluorine compounds in Japan and internationally. It offers hydrofluoric acid, buffered hydrofluoric acid, and etching solutions used in semiconductors and liquid crystal products; calcium, aluminum, lithium, strontium, barium, magnesium, and lead fluoride used in optical materials; and lithium hexafluorophosphate for batteries. The company also provides boron trifluoride, boron trifluoride diethyl ether, boron trifluoride dimethyl ether, boron trifluoride n-butyl ether, boron trifluoride tetrahydrofuran, boron trifluoride phenol, boron trifluoride monoethyl amine, boron trifluoride piperidine, and triethylamine 3HF used in reactive catalysts; and anhydrous hydrofluoric acid and 55% hydrofluoric acid used in surface treatment and alternatives for CFCs. In addition, it offers potassium fluoroborate and boric acid for nuclear energy applications; tin fluoride (II) USP used in GMP-compliant products; and other products, such as fluorosilicic acid, potassium fluorosilicate, fluoroboric acid, tin fluoroborate, copper fluoroborate, lead fluoroborate, zinc fluoroborate, sodium fluoroborate, potassium fluoroborate, ammonium hydrogenfluoride, sodium fluoride, potassium fluoride, ammonium fluoride, potassium hexafluorozirconate, potassium hexafluorotitanate, refined calcium fluoride, and potassium hexafluorophosphate. Further, the company transports a range of special chemical substances, high-pressure gas, hazardous materials, and related products. Additionally, it develops Boron Neutron Capture therapy for the treatment of cancer. The company was formerly known as Hashimoto Chemical Corporation and changed its name to Stella Chemifa Corporation in 1997. Stella Chemifa Corporation was founded in 1916 and is headquartered in Osaka, Japan.